Amfepramone-containing medicines will no longer be available on the EU market, as marketing authorisations will be revoked
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
|Therapeutic area (MeSH)||
Referral - Article 31
Amfepramone-containing medicinal products
|Human ATC code||